Skip to Content

MD Anderson Events

Targeting HIF1a and Tumor Architecture as a Means to Overcome Hypoxia Dependent Therapeutic Resistance

Targeting HIF1a and Tumor Architecture as a Means to Overcome Hypoxia Dependent Therapeutic Resistance

Seminar sponsored by the Department of Experimental Therapeutics

Date: 9/12/12, 9am to 10am
Time: 9/12/12, 9am to 10am
Location: South Campus - 4SCR1.1110
Format: Seminar/Conference
Speaker: Geoffrey Bartholomeusz, Ph.D.
Speaker Bio: Assistant Professor Director, siRNA Screening Service Department of Experimental Therapeutics MD Anderson Cancer Center
Contact: Nita Burke - 7923336 - nburke@mdanderson.org